Patient Guide: A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 63 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05133531
Status: 🟢 Enrolling Now
Condition: Paroxysmal Nocturnal Hemoglobinuria
Phase: PHASE3

Where You Can Participate

This study is available at 63 locations across the country.

Top locations include:
  • • Whittier, California
  • • Toronto, Ontario
  • • Beijing, Beijing Municipality
  • • And 60 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment - Join Clinical Trial NCTNCT05133531

How to Join This Clinical Trial - NCTNCT05133531

Learn how to participate in this PHASE3 trial studying an investigational therapy for Paroxysmal Nocturnal Hemoglobinuria. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Paroxysmal Nocturnal Hemoglobinuria. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Paroxysmal Nocturnal Hemoglobinuria
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05133531 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 63 locations. Find a study site near you:

Clinical Research Site

Whittier, California 90603 - United States

Status: RECRUITING

Clinical Research Site

Toronto, Ontario M5G2 C4 - Canada

Status: RECRUITING

Clinical Research Site

Beijing, Beijing Municipality 100032 - China

Status: COMPLETED

Clinical Research Site

Medellín, Antioquia 050034 - Colombia

Status: RECRUITING

Clinical Research Site

Thessaloniki, 57010 - Greece

Status: RECRUITING

Clinical Research Site

Budapest, 1088 - Hungary

Status: RECRUITING

Clinical Research Site

Kannur, Kerala 670103 - India

Status: RECRUITING

Clinical Research Site

Kochi, Kerala 682041 - India

Status: RECRUITING

Clinical Research Site

Mumbai, Maharashtra 400022 - India

Status: RECRUITING

Clinical Research Site

New Delhi, National Capital Territory of Delhi 110085 - India

Status: RECRUITING

And 53 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Paroxysmal Nocturnal Hemoglobinuria:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships